The Joint Corp. (NASDAQ: JYNT) is one of 49 publicly-traded companies in the “Healthcare Facilities & Services” industry, but how does it weigh in compared to its peers? We will compare The Joint Corp. to similar companies based on the strength of its analyst recommendations, dividends, earnings, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for The Joint Corp. and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Joint Corp. 0 0 4 0 3.00
The Joint Corp. Competitors 185 1260 1788 31 2.51

The Joint Corp. presently has a consensus target price of $6.15, suggesting a potential upside of 32.26%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 3.89%. Given The Joint Corp.’s stronger consensus rating and higher possible upside, research analysts plainly believe The Joint Corp. is more favorable than its peers.

Valuation and Earnings

This table compares The Joint Corp. and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
The Joint Corp. $22.97 million -$4.53 million -5.34
The Joint Corp. Competitors $5.55 billion $880.05 million 37.66

The Joint Corp.’s peers have higher revenue and earnings than The Joint Corp.. The Joint Corp. is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

47.0% of The Joint Corp. shares are held by institutional investors. Comparatively, 68.6% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 6.1% of The Joint Corp. shares are held by insiders. Comparatively, 15.2% of shares of all “Healthcare Facilities & Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

The Joint Corp. has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, The Joint Corp.’s peers have a beta of 1.01, suggesting that their average stock price is 1% more volatile than the S&P 500.

Profitability

This table compares The Joint Corp. and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Joint Corp. -48.08% -103.25% -42.06%
The Joint Corp. Competitors 6.93% 0.33% 0.51%

Summary

The Joint Corp. peers beat The Joint Corp. on 8 of the 12 factors compared.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.